A Second Chance for Johnson & Johnson in Court - WSJ
Johnson & Johnson – Products, Recalls, Lawsuits & Scandals
Morgan Stanley gives J&J overweight rating, says stock looks cheap
Johnson & Johnson shares rise after talc settlement offer
Johnson & Johnson Faces Another Crisis After Supreme Court Decision
J&J split could give consumer marketers badly needed freedom | Ad Age
Johnson & Johnson | LinkedIn
/https://static.texastribune.org/media/files/aadf548ad57ebd8538e7b3456aba30a6/JandJ%20REUTERS%20TT.jpg "Texas reaches $290 million opioid settlement with Johnson & Johnson | The Texas Tribune")
Texas reaches $290 million opioid settlement with Johnson & Johnson | The Texas Tribune
Johnson & Johnson to end global sales of talc-based baby powder | The Japan Times
Johnson & Johnson | Save the Children
Johnson & Johnson | Fierce Pharma
Johnson & Johnson to spin off consumer division
JOHNSON'S® | Johnson & Johnson Pediatrics
4 Ways Johnson & Johnson Is Cultivating Outside-the-Box Innovations for COVID-19
Our Brands | Johnson & Johnson Pediatrics
CDC: J&J COVID-19 vaccine no longer available in U.S.
Johnson & Johnson to spin off consumer arm to focus on medical division | Healthcare industry | The Guardian
Questions about Johnson & Johnson vaccine - Mayo Clinic Health System
Johnson & Johnson COVID-19 Vaccine: 6 Facts You Should Know | Cone Health
U.S. calls for pause on use of Johnson & Johnson Covid-19 vaccine
Johnson & Johnson to pay $8.9 billion to settle claims baby powder, other talc products caused cancer - ABC News
Johnson's® New 100% Ingredient Transparency Disclosure for Its Baby Products | Johnson & Johnson
Johnson & Johnson to settle metal-hip lawsuits for about $1 billion, sources say - Los Angeles Times
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
Home | J&J MedTech
Johnson & Johnson bankruptcy maneuver blocks baby powder cancer lawsuits : NPR
